Sonoma Pharmaceuticals
SNOA
#10105
Rank
A$5.63 M
Marketcap
$4.21
Share price
3.14%
Change (1 day)
-4.70%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2024 (TTM): -A$6.39 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are A$13.54 Million. In 2023 the company made an earning of -A$7.1 Million, an increase over its 2022 earnings that were of -A$10.37 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$6.39 Million-10.11%
2023 -A$7.1 Million-31.5%
2022 -A$10.37 Million16.86%
2021 -A$8.87 Million194.32%
2020 -A$3.02 Million-58.76%
2019 -A$7.31 Million-65.66%
2018 -A$21.28 Million4.84%
2017 -A$20.3 Million-2.17%
2016 -A$20.75 Million32.12%
2015 -A$15.71 Million-307.74%
2014 A$7.55 M-197.5%
2013 -A$7.76 Million
2010 -A$12.12 Million-14.02%
2009 -A$14.09 Million-57.28%
2008 -A$32.98 Million-8.03%
2007 -A$35.86 Million3.85%
2006 -A$34.53 Million39.31%
2005 -A$24.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$29.04 Million 324.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.19 Billion 2,655.87%๐Ÿ‡บ๐Ÿ‡ธ USA